I received my Ph.D. from Seoul National University in 2017, where I investigated the mechanisms by which the gut microbiota regulates immune tolerance in birds. I subsequently conducted postdoctoral research at the Korea Institute of Science and Technology (KIST), focusing on the mechanisms of microbiota-derived molecules involved in immunotherapy for colorectal cancer. Following my postdoctoral research, I spent five years working on the research and development of FMDV virus-like particle (VLP) vaccines. I am currently involved in the development of an African swine fever (ASF) vaccine using herpesviruses as viral vectors.